Optimization Studies on Gastroretentive Floating System Using Response Surface Methodology

被引:27
作者
Awasthi, Rajendra [1 ]
Kulkarni, Giriraj T. [1 ]
Pawar, Vivek K. [2 ]
Garg, Garima [3 ]
机构
[1] Laureate Inst Pharm, Dehra, Himachal Prades, India
[2] Kusum Heathcare, New Delhi 110055, India
[3] Meerut Inst Engn & Technol, Dept Pharmaceut Technol, Meerut 250005, Uttar Pradesh, India
关键词
amoxicillin; central composite design; floating microballoons; gastroretentive floating system; H; pylori; response surface methodology; DRUG-DELIVERY-SYSTEM; IN-VITRO; MICROSPHERES; MICROBALLOONS; FORMULATION; RELEASE;
D O I
10.1208/s12249-011-9730-y
中图分类号
R9 [药学];
学科分类号
100702 [药剂学];
摘要
The aim of the present investigation was to develop and optimize gastroretentive floating system of amoxicillin for the efficient treatment of peptic ulcer induced by Helicobacter pylori infection. Floating microballoons were developed using central composite design (CCD), and optimization was done by employing response surface methodology. The selected independent variables were cellulose acetate phthalate, drug-Eudragit S100 ratio, and the ratio of dichloromethane/ethanol/isopropyl alcohol. The selected dependent variables were yield, mean particle size, buoyancy, encapsulation efficiency, and drug release within 8 h. A quadratic polynomial model was generated which had linear, interaction, and quadratic terms to predict and evaluate the independent variables with respect to the dependent variables. Results showed that selected independent variables significantly affect the yield (30.53-82.71%), particle size (31.62-47.03 mu m), buoyancy (42.68-95.75%), encapsulation efficiency (56.96-93.13%), and cumulative drug release from the microballoons (34.01-74.65%). The interaction and quadratic terms were also found to affect the process variables. An excellent agreement was found between the actual value and predicted value. In conclusion, it can be said that CCD is a valuable second-degree design to develop and optimize GFS of amoxicillin which in turn provides a basis to localize the drug release in the gastric region for effective treatment of H. pylori-mediated infection.
引用
收藏
页码:85 / 93
页数:9
相关论文
共 16 条
[1]
Floating drug delivery systems: A review [J].
Arora, S ;
Ali, J ;
Ahuja, A ;
Khar, RK ;
Baboota, S .
AAPS PHARMSCITECH, 2005, 6 (03) :E372-E390
[2]
Gastroretentive dosage forms:: Overview and special case of Helicobacter pylori [J].
Bardonnet, PL ;
Faivre, V ;
Pugh, WJ ;
Piffaretti, JC ;
Falson, F .
JOURNAL OF CONTROLLED RELEASE, 2006, 111 (1-2) :1-18
[3]
Celluose acetate microspheres as floating depot systems to increase gastric retention of antidiabetic drug:: Formulation, characterization and in vitro-in vivo evaluation [J].
Choudhury, Pratim K. ;
Kar, Mousumi ;
Chauhan, Chetan S. .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2008, 34 (04) :349-354
[4]
Formulation strategies for absorption windows [J].
Davis, SS .
DRUG DISCOVERY TODAY, 2005, 10 (04) :249-257
[5]
Calcium silicate based microspheres of repaglinide for gastroretentive floating drug delivery: Preparation and in vitro characterization [J].
Jain, SK ;
Awasthi, AM ;
Jain, NK ;
Agrawal, GP .
JOURNAL OF CONTROLLED RELEASE, 2005, 107 (02) :300-309
[6]
Lee JH, 1999, J MICROENCAPSUL, V16, P715
[7]
MAJUMDAR D, 2007, MEDICINE, V35, P204
[8]
Preparation of floating microspheres for fish farming [J].
Nepal, Pushp R. ;
Chun, Myung-Kwan ;
Choi, Hoo-Kyun .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2007, 341 (1-2) :85-90
[9]
Patel Jayvadan K., 2007, Current Drug Delivery, V4, P41, DOI 10.2174/156720107779314811
[10]
PEPPAS NA, 1985, PHARM ACTA HELV, V60, P110